Estrategias Combinadas en Inmunoterapia Traslacional
ITC
National Institute of Allergy and Infectious Diseases
Bethesda, Estados UnidosPublications en collaboration avec des chercheurs de National Institute of Allergy and Infectious Diseases (1)
2021
-
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type i conventional dendritic cells
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5